IDEXX Laboratories GAAP EPS of $2.62 beats by $0.22, revenue of $954M beats by $17.32M (IDXX:NASDAQ)

by


  • IDEXX Laboratories press release (NASDAQ:IDXX): Q4 GAAP EPS of $2.62 beats by $0.22.
  • Revenue of $954M (+5.8% Y/Y) beats by $17.32M.
    • Provides initial outlook for 2025 revenue of $4,055 million – $4,170 million vs $4.15B consensus, reflecting growth of 4% – 7% reported and 6% – 9% organic, supported by CAG Diagnostics


Leave a Comment